David Dickens

718 total citations · 1 hit paper
19 papers, 507 citations indexed

About

David Dickens is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Biochemistry. According to data from OpenAlex, David Dickens has authored 19 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Pediatrics, Perinatology and Child Health and 5 papers in Biochemistry. Recurrent topics in David Dickens's work include Drug Transport and Resistance Mechanisms (9 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Amino Acid Enzymes and Metabolism (5 papers). David Dickens is often cited by papers focused on Drug Transport and Resistance Mechanisms (9 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Amino Acid Enzymes and Metabolism (5 papers). David Dickens collaborates with scholars based in United Kingdom, United States and Germany. David Dickens's co-authors include Munir Pirmohamed, Andrew Owen, S.S. Hasnain, S.V. Antonyuk, Athina Giannoudis, Ana Alfirevic, Steven D. Webb, Babette B. Weksler, Ignacio A. Romero and Pierre‐Olivier Couraud and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

David Dickens

19 papers receiving 498 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Crossing the blood–brain barrier: emerging therapeutic strategies for neurological disease

2025 22 citations Adam M. Sonabend, Benedict Michael et al. The Lancet Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Dickens United Kingdom	14	192	185	131	106	62	19	507
Yutaro Hoshi Japan	10	316 1.6×	210 1.1×	64 0.5×	136 1.3×	67 1.1×	14	588
Kimio Tohyama Japan	14	275 1.4×	195 1.1×	43 0.3×	146 1.4×	57 0.9×	36	709
Kazuhiro Tetsuka Japan	11	201 1.0×	160 0.9×	79 0.6×	60 0.6×	50 0.8×	16	495
Salah Yousif France	8	399 2.1×	183 1.0×	62 0.5×	192 1.8×	106 1.7×	15	760
Yoshiyuki Tenda Japan	9	308 1.6×	129 0.7×	46 0.4×	208 2.0×	48 0.8×	10	545
Kouichi Kawazu Japan	13	169 0.9×	188 1.0×	34 0.3×	113 1.1×	47 0.8×	29	616
Toshiki Kurosawa Japan	12	119 0.6×	91 0.5×	35 0.3×	45 0.4×	45 0.7×	20	301
Lucy Sanchez‐Covarrubias United States	7	220 1.1×	160 0.9×	35 0.3×	91 0.9×	62 1.0×	7	550
Scott M. Ocheltree United States	11	220 1.1×	93 0.5×	72 0.5×	96 0.9×	42 0.7×	12	454
Andrea Sovic Austria	7	123 0.6×	289 1.6×	72 0.5×	30 0.3×	24 0.4×	7	609

Countries citing papers authored by David Dickens

Since Specialization

Citations

This map shows the geographic impact of David Dickens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Dickens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Dickens more than expected).

Fields of papers citing papers by David Dickens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Dickens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Dickens. The network helps show where David Dickens may publish in the future.

Co-authorship network of co-authors of David Dickens

This figure shows the co-authorship network connecting the top 25 collaborators of David Dickens. A scholar is included among the top collaborators of David Dickens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Dickens. David Dickens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Sonabend, Adam M., Benedict Michael, Rasheed Zakaria, et al.. (2025). Crossing the blood–brain barrier: emerging therapeutic strategies for neurological disease. The Lancet Neurology. 24(3). 246–260. 22 indexed citations breakdown →

Smith, Mark A., H. Ralph Snodgrass, Munir Pirmohamed, et al.. (2024). Role of Transporters and Enzymes in Metabolism and Distribution of 4-Chlorokynurenine (AV-101). Molecular Pharmaceutics. 21(2). 550–563. 5 indexed citations

Cappoli, Natalia, Michael D. Jenkinson, Cinzia Dello Russo, & David Dickens. (2022). LAT1, a novel pharmacological target for the treatment of glioblastoma. Biochemical Pharmacology. 201. 115103–115103. 28 indexed citations

Bourque, Mélanie, et al.. (2022). AV-101, a Pro-Drug Antagonist at the NMDA Receptor Glycine Site, Reduces L-Dopa Induced Dyskinesias in MPTP Monkeys. Cells. 11(22). 3530–3530. 7 indexed citations

Sakai, Keiko, Yuki Taga, Tomonori Ueno, et al.. (2021). The dipeptide prolyl-hydroxyproline promotes cellular homeostasis and lamellipodia-driven motility via active β1-integrin in adult tendon cells. Journal of Biological Chemistry. 297(1). 100819–100819. 18 indexed citations

Dickens, David, et al.. (2021). Inflammatory Bowel Disease: A Personalized Approach. Frontiers in Pediatrics. 8. 620545–620545. 2 indexed citations

Gutbier, Simon, Stefan Schildknecht, Frank W. Lewis, et al.. (2020). Design and evaluation of bi-functional iron chelators for protection of dopaminergic neurons from toxicants. Archives of Toxicology. 94(9). 3105–3123. 29 indexed citations

Smith, Martin, Mark A. Smith, H. Ralph Snodgrass, et al.. (2020). Probenecid Increases the Concentration of 7-Chlorokynurenic Acid Derived from the Prodrug 4-Chlorokynurenine within the Prefrontal Cortex. Molecular Pharmaceutics. 18(1). 113–123. 13 indexed citations

Dickens, David, Athina Giannoudis, Michael Cross, et al.. (2018). Cellular Uptake of the Atypical Antipsychotic Clozapine Is a Carrier-Mediated Process. Molecular Pharmaceutics. 15(8). 3557–3572. 28 indexed citations

10.

Dickens, David, et al.. (2017). Modulation of LAT1 (SLC7A5) transporter activity and stability by membrane cholesterol. Scientific Reports. 7(1). 43580–43580. 62 indexed citations

11.

Curley, Paul, Marco Giardiello, Neill J. Liptrott, et al.. (2017). In vitro characterisation of solid drug nanoparticle compositions of efavirenz in a brain endothelium cell line. 2(3). 157–169. 2 indexed citations

12.

Alfirevic, Ana, Jill Durocher, David Dickens, et al.. (2015). Misoprostol-Induced Fever and Genetic Polymorphisms in Drug Transporters SLCO1B1 and ABCC4 in Women of Latin American and European Ancestry. Pharmacogenomics. 16(9). 919–928. 13 indexed citations

13.

Dickens, David, Thomas Lang, Laura Bonnett, et al.. (2014). A comprehensive functional and clinical analysis of ABCC2 and its impact on treatment response to carbamazepine. The Pharmacogenomics Journal. 14(5). 481–487. 5 indexed citations

14.

Dickens, David, Siti R. Yusof, N. Joan Abbott, et al.. (2013). A Multi-System Approach Assessing the Interaction of Anticonvulsants with P-gp. PLoS ONE. 8(5). e64854–e64854. 26 indexed citations

15.

Dickens, David, Andrew Owen, Ana Alfirevic, & Munir Pirmohamed. (2013). ABCB1 single nucleotide polymorphisms (1236C>T, 2677G>T, and 3435C>T) do not affect transport activity of human P-glycoprotein. Pharmacogenetics and Genomics. 23(6). 314–323. 24 indexed citations

16.

Dickens, David, Steven D. Webb, S.V. Antonyuk, et al.. (2013). Transport of gabapentin by LAT1 (SLC7A5). Biochemical Pharmacology. 85(11). 1672–1683. 105 indexed citations

17.

Vogler, Meike, David Dickens, Martin J.S. Dyer, et al.. (2011). The B-cell lymphoma 2 (BCL2)-inhibitors, ABT-737 and ABT-263, are substrates for P-glycoprotein. Biochemical and Biophysical Research Communications. 408(2). 344–349. 19 indexed citations

18.

Dickens, David, Andrew Owen, Ana Alfirevic, et al.. (2011). Lamotrigine is a substrate for OCT1 in brain endothelial cells. Biochemical Pharmacology. 83(6). 805–814. 70 indexed citations

19.

Lam, David, et al.. (2009). MAP4K3 modulates cell death via the post-transcriptional regulation of BH3-only proteins. Proceedings of the National Academy of Sciences. 106(29). 11978–11983. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact